MedTrace Logo

Visual Outcomes and Patient Satisfaction With Implantation of the Clareon Monofocal IOL With the New Clareon Manual Monarch IV IOL Delivery System

NCT05526781 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2025-03-26

Study results available
· View outcomes & findings →

Summary

To evaluate visual outcomes, in-the-bag placement and patient satisfaction in patients implanted with either Clareon monofocal or Clareon monofocal toric IOLs with the Monarch IV inserter and targeted for emmetropia.

Conditions

  • Cataract

Interventions

DEVICE

Clareon monofocal Intraocular lens (toric and non-toric models)

Bilateral implantation of the Clareon monofocal Intraocular lens (toric and non-toric models) with the Monarch IV inserter

Sponsors & Collaborators

  • Sengi

    collaborator INDUSTRY

  • Eye Consultants of Atlanta

    lead OTHER

Principal Investigators

  • Joesph Christenbury, MD · Eye Consultants of Atlanta

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-21
Primary Completion
2024-03-12
Completion
2024-03-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05526781 on ClinicalTrials.gov